CDEK
← All organizations

Pharmasset

For profitContributed to NME
Phase 1Phase 2Phase 3Phase 4

Highest phase reached

Phase 3

First clinical trial

Jun 1, 2002

Last known activity

Jun 1, 2011

Acquired by Gilead Sciences on Jan 1, 2012

Timeline

1990s

  1. Jan 1, 1998

    Pharmasset— Founded

2010s

  1. Jan 1, 2012

    Gilead Sciences— Acquired By

Drugs by trial phase (9 distinct, 8 trials)

Phase 3 (3 own, 0 via acquisition)

Phase 2 (5 own, 0 via acquisition)

Phase 1 (1 own, 0 via acquisition)

Indications

Studied for

Recent trials (11)

Details

Founded
Princeton, NJ, US Jan 1, 1998
Last known activity
Jun 1, 2011